| 000 | 01900 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515232753.0 | ||
| 264 | 0 | _c20110330 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1523-4681 | ||
| 024 | 7 |
_a10.1002/jbmr.180 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGamsjaeger, Sonja | |
| 245 | 0 | 0 |
_aBone material properties in actively bone-forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once-yearly Zoledronic acid. _h[electronic resource] |
| 260 |
_bJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _cJan 2011 |
||
| 300 |
_a12-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBone and Bones _xdrug effects |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aOsteogenesis _xdrug effects |
| 650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xdrug therapy |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 |
_aProteoglycans _xmetabolism |
| 650 | 0 | 4 | _aSpectrum Analysis, Raman |
| 650 | 0 | 4 | _aZoledronic Acid |
| 700 | 1 | _aBuchinger, Birgit | |
| 700 | 1 | _aZwettler, Elizabeth | |
| 700 | 1 | _aRecker, Robert | |
| 700 | 1 | _aBlack, Dennis | |
| 700 | 1 | _aGasser, Juerg A | |
| 700 | 1 | _aEriksen, Erik F | |
| 700 | 1 | _aKlaushofer, Klaus | |
| 700 | 1 | _aPaschalis, Eleftherios P | |
| 773 | 0 |
_tJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _gvol. 26 _gno. 1 _gp. 12-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jbmr.180 _zAvailable from publisher's website |
| 999 |
_c19986471 _d19986471 |
||